NEW DELHI, 22 September 2021: FICCI, jointly with Apollo Hospital, Department of Health Research, AIIMS, Bhopal AIIMS, Jammu and Novartis is organizing a virtual conclave ‘Integrating Methods of Pharmaco-economics to Accelerate Healthcare Transformation’ on 23 September 2021.
The Conclave is envisioned to advance the concept of health economics and outcome research (clinical, economic, and patient reported) as well as health technology to foster and integrate the use of these concepts for effective health care decision-making.
The aim of the conclave is to strengthen the implementation of health technologies and interventions systematically and actively use them in decision-making and planning process across all key stakeholders in health ecosystem.
Eminent speakers slated to address include Prof Balram Bhargava, Secretary, Department of Health Research, Indian Council of Medical Research, Government of India; Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group & Past President, FICCI; Prof YK Gupta, President, AIIMS Bhopal & AIIMS, Jammu; Dr KT Bhowmik, Principal Consultant, DGHS, MoHFW; Dr Alka Ahuja, CMO (Drugs), CGHS; Dr Abha Mehndiratta, Technical Adviser India, iDSI; Amogh Dev Rai, Executive Director, Sanrachna; Dr Kavitha Rajsekhar, Scientist E, DHR, Government of India; Dr Shankar Prinja, Additional Professor- Health Economics, (PGIMER), Chandigarh; Dr AK Pandey, Director ESI Medical College, Faridabad; Dr Aseem Das, Dean, ESI Medical College, Faridabad; Subratta Bhattacharaya, Founding Director, Pharma Quant; Prof Lt Colonel Prafful Mohan, AFMC, Pune; Air Commodore (Dr) Ranjan Kumar Choudhury VSM, NHSRC; Laura Downey, Senior Research Fellow, The George Institute for Global Health-London; Sanjay Murdeshwar, CP & Managing Director, Novartis and Gilbert Verkuijlen, Value & Access Head, APMA, NAPP – APMA Patient Access.
Medical Directors, procurement agency heads, healthcare providers, clinicians, researchers, academicians, students can also participate and explore how concepts of Health Economics and Outcome Research and Health Technology can be integrated within the existing framework for enabling evidence-based decisions.
The experts will discuss debate and share information on health technology issues as well as bridge the gap between health care decision makers and outcomes researchers to optimize health related decisions to tackle major health challenges. In addition, the conclave will provide unique opportunity to share views, challenges and opportunities to strengthen the concepts of pharmaco-economics to maximize impact.
